Versant Capital Management, Inc - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 109 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Versant Capital Management, Inc ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2023$16,576
-1.5%
268
-26.8%
0.01%0.0%
Q3 2023$16,832
-31.2%
366
-14.1%
0.01%
-37.5%
Q2 2023$24,482
+43.0%
426
-6.6%
0.01%
+33.3%
Q1 2023$17,125
+28.9%
456
-3.8%
0.01%
+20.0%
Q4 2022$13,281
+2.2%
4740.0%0.01%0.0%
Q3 2022$13,000
-23.5%
474
-0.2%
0.01%
-16.7%
Q2 2022$17,000
-10.5%
475
-7.9%
0.01%0.0%
Q1 2022$19,000
+46.2%
516
-8.5%
0.01%
+50.0%
Q4 2021$13,000
+30.0%
564
+12.1%
0.00%0.0%
Q3 2021$10,000
-9.1%
503
-8.4%
0.00%0.0%
Q2 2021$11,000
+22.2%
549
+16.1%
0.00%
+33.3%
Q1 2021$9,0000.0%4730.0%0.00%
-25.0%
Q4 2020$9,000
+12.5%
4730.0%0.00%0.0%
Q3 2020$8,000
-20.0%
4730.0%0.00%
-20.0%
Q2 2020$10,000
+66.7%
473
+2.2%
0.01%
+66.7%
Q1 2020$6,000463
+2004.5%
0.00%
Q4 2018$022
+83.3%
0.00%
Q3 2018$012
-20.0%
0.00%
Q2 2018$0150.0%0.00%
Q1 2018$015
-65.1%
0.00%
Q4 2017$0430.0%0.00%
Q3 2017$0
-100.0%
43
-81.3%
0.00%
-100.0%
Q2 2017$4,0002300.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2018
NameSharesValueWeighting ↓
LAM GROUP, INC. 128,000$5,886,7205.78%
Beacon Harbor Wealth Advisors, Inc. 103,095$4,7411.58%
Capital Impact Advisors, LLC 15,304$703,8311.18%
Quantedge Capital Pte Ltd 36,389$1,673,5300.91%
Mesirow Institutional Investment Management, Inc. 183,805$8,453,1920.86%
Monashee Investment Management LLC 39,461$1,814,8110.76%
OBERWEIS ASSET MANAGEMENT INC/ 152,500$7,013,4750.74%
Granite Investment Partners, LLC 330,911$15,218,5970.64%
Portolan Capital Management 132,850$6,109,7720.57%
SHAKER INVESTMENTS LLC/OH 20,795$956,3620.53%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders